TerminatedPhase 4

Non-surgical Alternatives to Treatment of Failed Medical Abortion

Stopped: Funding mechanism compromised

United States16 participantsStarted 2016-06-01

Plain-language summary

The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have ultrasound evidence of an ongoing pregnancy (embryo with cardiac activity) \<= 77 days gestational age at follow-up after using a mifepristone-misoprostol regimen for termination of pregnancy * Agree to comply with study procedures * Able to consent to study participation Exclusion Criteria: * Have an ongoing pregnancy but did not take an initial course of mifepristone and misoprostol at the study site * Are \< 18 years old in US and Canadian sites * Present with other medical abortion outcomes including persistent non-viable pregnancies or empty sac * Are unable to provide contact information for follow-up purposes

What they're measuring

The proportion of women in each study group, by gestational age cohort, who have a successful abortion without recourse to surgical intervention for any reason.

Timeframe: One week after taking first study medication

Trial details

NCT IDNCT02704481

SponsorGynuity Health Projects

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01-16

View on ClinicalTrials.gov More Abortion Failure trials